InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Paradigm Biocapital Advisors LP. Insider active across 1 company, notably Olema Pharmaceuticals, Inc.. Cumulatively, 2 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €26.9m. Activity tracked since 6 December 2023. The latest transaction was filed on 1 August 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations